
Granspas DM 80mg/250mg Tablet
Marketer
Granmed Pharma
Salt Composition
Drotaverine (80mg) + Mefenamic Acid (250mg)
Overview Granspas DM 80mg/250mg Tablet
Abdominal pain relief is provided by the combined-action formula of Dolux 80mg/250mg Tablets. This medication effectively alleviates abdominal pain, bloating, discomfort, and cramping through the relaxation of stomach and intestinal muscles. It also inhibits pain-inducing chemical signals. Dolux 80mg/250mg Tablets are administered with meals, following your doctor's prescribed dosage and regimen. Your individual dosage will be determined by your condition and treatment response. Continue taking this medication as directed by your physician; premature discontinuation may lead to symptom recurrence and condition exacerbation. Inform your healthcare provider of all other medications you are using, as interactions are possible. Common side effects include diarrhea, nausea, vomiting, stomach upset, dry mouth, appetite loss, thirst, and heartburn. These are usually transient and self-limiting. Report any concerning side effects to your doctor immediately. Dizziness and drowsiness are potential side effects; avoid driving or activities requiring alertness until you assess your response to the medication. Alcohol consumption should be avoided due to the risk of increased dizziness. Before starting this medication, inform your doctor if you are pregnant, planning pregnancy, or breastfeeding. Also disclose any existing kidney or liver conditions to allow for appropriate dosage adjustment.
Primary Ingredients of Granspas DM 80mg/250mg Tablet
No text was provided. Please provide the text you wish me to rephrase.
Uses of Granspas DM 80mg/250mg Tablet
Managing abdominal discomfort
Major Benefits of Granspas DM 80mg/250mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the entire tablet; avoid chewing, crushing, or breaking it. Consume Granspas DM 80mg/250mg tablets with food.
Common Side effects of Granspas DM 80mg/250mg Tablet:
- Nausea
- Vomiting
- Diarrhea
- Dryness in mouth
- Heartburn
- Vertigo
- Insomnia (difficulty in sleeping)
- Hypotension (low blood pressure)
- Fast heart rate
- Sweating
- Constipation
- Increased liver enzymes
- Increased white blood cell count (eosinophils)
- Decreased white blood cell count (lymphocytes)
- Low blood platelets
- Purpura
- Agranulocytosis (deficiency of granulocytes in the blood)
- Breathlessness
- Ringing in ear
- Abdominal pain
- Flatulence
- Indigestion
- Stomach inflammation
- Confusion
- Depression
How to use Granspas DM 80mg/250mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 80mg/250mg Granspas DM tablet whole; do not crush, chew, or divide it. Administer this medicine with food.
How Granspas DM 80mg/250mg Tablet works:
Each Granspas DM 80mg/250mg tablet combines drotaverine and mefenamic acid to alleviate abdominal pain and cramping. Drotaverine, an antispasmodic, targets and reduces painful abdominal muscle contractions. Mefenamic acid, a nonsteroidal anti-inflammatory drug (NSAID), inhibits the production of substances triggering abdominal pain and inflammation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Granspas DM 80mg/250mg Tablets poses a safety risk.
PregnancyCONSULT YOUR DOCTOR
The use of Granspas DM 80mg/250mg tablets during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the advantages against possible risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Granspas DM 80mg/250mg Tablet while breastfeeding is lacking. A physician's advice is recommended.
DrivingUNSAFE
Driving ability may be impaired by Granspas DM 80mg/250mg Tablets, a potential side effect of this medication due to the risk of dizziness.
KidneyCAUTION
Patients with kidney impairment should use the 80mg/250mg Granspas DM tablet cautiously, potentially requiring dosage modification. Physician consultation is advised. The 80mg/250mg Granspas DM tablet is contraindicated in patients with severe kidney disease.
LiverCAUTION
Patients with hepatic impairment should use Granspas DM 80mg/250mg tablets cautiously. Dosage modification of Granspas DM 80mg/250mg tablets may be necessary; physician consultation is advised.
What if you forget to take Granspas DM 80mg/250mg Tablet :
Should you forget a dose of Granspas DM 80mg/250mg Tablet, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Granspas DM 80mg/250mg Tablet
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
